- Home
- BSBR vs EW Comparison
BSBR vs EW Comparison
Compare BSBR & EW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BSBR | EW |
|---|---|---|
| Founded | 1970 | 1958 |
| Country | Brazil | United States |
| Employees | N/A | N/A |
| Industry | Commercial Banks | Industrial Specialties |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 43.5B | 49.1B |
| IPO Year | 2009 | 1999 |
Fundamental Metrics
Financial Performance| Metric | BSBR | EW |
|---|---|---|
| Price | $5.74 | $85.68 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 3 | 29 |
| Target Price | $6.77 | ★ $101.96 |
| AVG Volume (30 Days) | ★ 3.4M | 3.4M |
| Earning Date | 07-29-2026 | 11-04-2026 |
| Dividend Yield | ★ 5.06% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 1.07 |
| Revenue | N/A | ★ $6,067,600,000.00 |
| Revenue This Year | $3.69 | $11.46 |
| Revenue Next Year | $7.93 | $9.92 |
| P/E Ratio | ★ $11.02 | $80.48 |
| Revenue Growth | N/A | ★ 11.55 |
| 52 Week Low | $4.95 | $72.40 |
| 52 Week High | $7.32 | $96.29 |
Technical Indicators
Market Signals| Indicator | BSBR | EW |
|---|---|---|
| Relative Strength Index (RSI) | 49.05 | 46.22 |
| Support Level | $5.72 | $83.49 |
| Resistance Level | $6.00 | $86.19 |
| Average True Range (ATR) | 0.13 | 1.95 |
| MACD | 0.01 | 0.01 |
| Stochastic Oscillator | 59.72 | 58.89 |
Price Performance
Historical ComparisonAbout BSBR Banco Santander Brasil SA each representing one unit
Banco Santander (Brasil) SA is part of Santander Group, a Spanish bank. It operates across two segments; the Commercial Banking segment, catering to both individual and corporate client and the Global Wholesale Banking segment, which encompasses Investment Banking and Markets operations, including the Treasury and Equity Business Departments. The bank generates majority of its revenue from the Commercial Banking segment and has operations in Brazil and internationally.
About EW Edwards Lifesciences Corporation
Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter aortic valves, and transcatheter mitral and tricuspid valve technologies. The firm derives about 60% of its total sales from outside the US.